CD36-positive CD8-positive T cells exhibit compromised immune functions, and a high level of infiltration of CD36-positive CD8-positive T cells predicts poor prognosis and inferior response to chemotherapy in patients with non-small cell lung cancer (Ao et al., 2023). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.